Personalising pancreas cancer treatment: When tissue is the issue

The treatment of advanced pancreatic cancer has not moved much beyond single agent gemcitabine until recently when protocols such as FOLFIRINOX (fluorouracil, leucovorin, irinotecan and oxaliplatin) and nab-paclitaxel-gemcitabine have demonstrated some improved outcomes. Advances in technology espec...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Sjoquist, Katrin M, Chin, Venessa T, Chantrill, Lorraine A, O’Connor, Chelsie, Hemmings, Chris, Chang, David K, Chou, Angela, Pajic, Marina, Johns, Amber L, Nagrial, Adnan M, Biankin, Andrew V, Yip, Desmond
Médium: Artigo
Jazyk:Inglês
Vydáno: Baishideng Publishing Group Inc 2014
Témata:
Topic Highlight
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4069313/
https://ncbi.nlm.nih.gov/pubmed/24976722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i24.7849
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky